PROGRAM OVERVIEW

This program will equip students with solid theoretical and systematic professional knowledge in molecular medicine, biomedical engineering, and related fields. Graduates of this program will have the opportunity to undertake independent scientific research, allowing them to understand the current status and future trends of medicine/biomedical engineering, and write and communicate in English.

MAIN RESEARCH FIELDS:

1. Biomedical information

Apply biomedical engineering techniques and methods to collect, analyze and evaluate health-related biomedical information, establish disease risk prediction and early warning models, explore the underlying reasons of disease pathogenesis, and conduct intervention studies.

2. Cell and tissue engineering

Conduct research on various types of stem cell and bioscaffold materials, and learn how to apply tissue engineering and regeneration technologies to acute and chronic injuries and diseases; conduct research using cell engineering and nanomaterial labeling technologies based on modern gene technology; perform in vivo and in vitro cell tracing and monitoring; and develop new sources of stem cells for research and industrialization amplification technologies, including the development of 3D culture and amplification and bioreactor systems.

3. Systematic Biomedical:

Harness biophysical, biochemical, bioinformatic and systems biology approaches to study human aging and major diseases such as cancer, cardiovascular and cerebrovascular diseases, metabolic diseases, and infectious diseases; use cells, tissues, organs to conduct translational medicine research into human disease mechanisms at multiple levels, and develop personalized and precise diagnostic and treatment approaches.

CORE COURSES

Frontiers in Biomedical Engineering, Biomedical Image Analysis, Lecture on Pattern Recognition Front, Advanced Cell Biology and Disease, Biochemistry and Molecular Biology.

CAREER PROSPECTS

There is a wide spectrum of career paths that can follow from obtaining a PhD in Biomedical Engineering, including but not limited to:

Biomedical Scientist/Researcher Biomedical scientists and researchers, in both clinical and/or research environments, conduct research that aims to improve human health by carrying out scientific tests to find solutions to medical/clinical problems. They research information that aids in the development of biomedical technology and test products so that they are safe and effective for consumers.

Biomaterials DeveloperBiomedical engineers may develop biomaterials based on either natural living tissue or artificial materials, for use in the human body. Tissue engineering, biomedical implant development, drug delivery and nano implants are all areas that a biomaterials developer may work in. Biomaterials can be used to either repair or replace lost function to the body, or to detect and image disease.

Biomedical Artificial Intelligent (AI) Researcher or Developer AI technology is rewiring many parts of society. How medical/clinical procedures and philosophies will be affected by AI is a thrilling frontier for exploration. A career in this field will involve you not only in science and technology, but also in areas of ethics, finance, and regulation.

Rehabilitation EngineerBiomedical engineers who work in a field dedicated to rehabilitation often work on diverse projects. These can range from mechanical equipment that helps patients regain the ability to walk, to virtual reality systems that aid in limb mobility. Rehabilitation engineers may also create custom solutions based on unique needs or research improvements that can form the basis of a novel rehabilitation technology.

Medical Device/Technology Developer

Medical technology can refer to the hardware and software that help manufacture medical devices, as well as to the technology that is an integral part of those devices. Medical technology professionals with biomedical engineering backgrounds may specialize in bioinstrumentation, or the use of bioelectronic/biomechanical/biochemical instruments to record or transmit physiological information in vivo and/or in vitro.

Consultation

Email:   [email protected]                

英文名

HaiqiangWu

聯系郵箱

[email protected]

中文簡介

博士，教授，博士生導師，深圳市高層次人才等。主要研究領域為藥物化學和化學生物學，研究方向涉及AD、腫瘤等系統性復雜疾病藥物作用新靶點的發現、網絡靶向新藥物分子的設計、合成、功能及作用分子機制研究等。先后主持國家自然科學基金面上項目、廣東省社會發展領域科技計劃項目、深圳市“新技術、新產品、新工藝”項目、深圳市科技計劃項目、深圳市國際合作項目等多項，已在J Med Chem等國際重要刊物上發表學術論文70多篇，申請新藥國際專利PCT 1 項，授權新藥國家發明專利9項，實審新藥發明專利20項，獲得廣東省科學技術進步獎（二等，2010年、2017年）2項，深圳市科技創新獎（高等院校類，2008年）1項等。

英文簡介

Ph.D., Professor, Ph.D. Supervisor. I am a professor in Medicinal Chemistry and Chemical Biology. My lab mainly focuses on the design, synthesis, and evaluation of novel molecules targeting Glutaminyl cyclase, iso-Glutaminyl cyclase and other proteins as potential anti-AD and anti-cancer agents. I pay particular attention in exploring the mechanism underlying the regulation of up-regulated QC and iso-QC in the initiation of AD and caners at the early stage. Research in my lab has been continuously supported by 4 regular grants of the National Natural Science Foundation in China (NSFC), 1 grant of Basic Research Foundation of Guangdong, 4 grants of Basic Research Foundation of Shenzhen, etc since 2015. I have published more than 70 papers in the peer-reviewed professional journals. I am currently mentoring 1 postdoctoral fellows, 2 PhD candidates and 17 MSc candidates.

英文名

Peng Gong

聯系郵箱

[email protected]

中文簡介

鞏鵬，教授、主任醫師、博士/博士后合作導師、深圳大學總醫院副院長、普外科主任。從醫27年來，鞏鵬教授一直致力于消化道腫瘤的臨床與基礎研究。先后參與撰寫多項中英文臨床指南與教材；在國家自然基金、高等學校博士學科點專項科研基金、省自然科學基金等十余項基金資助下，圍繞消化道腫瘤發病及耐藥機制先后在《Journal of Advanced Research》、《Theranostics》以及《Oncogene》等國內外期刊雜志發表論文150余篇，申請專利8項。上述研究成果先后獲得省、市級科技進步獎10余項。

英文簡介

I am the chief physician and the deputy dean of Shenzhen University General Hospital. I have two excellent teams which focus on clinical and basic cancer research. As the co-author, I wrote a number of clinical guidelines and textbooks in both Chinese and English. Supported by more than ten funds such as the National Natural Science Foundation of China, the Special Scientific Research Fund for Doctoral Programs in Higher Education, and the Provincial Natural Science Foundation, I try to clarify the mechanism of the gastrointestinal tumors and drug resistance. I discovered that the tumor environment plays an important role in tumor development and chemotherapeutic drug resistance. For example, we observed that the levels of macrophages and activated dendritic cells in tumor tissues were significantly higher than that in para-tumor tissues. Macrophages, gamma delta T cells and naive CD4 T cells were independent predictive factors of a poor outcome for pancreatic ductal adenocarcinoma patients. Subsequently, I observed that autophagy and Hippo-YAP1 signaling pathway, two processes, has been reported to regulate the pathophysiology of cancer and the sensitivity to chemotherapy. Bafilomycin A1, an inhibitor of autophagy, could induce caspase-independent cell death via targeting of autophagy and MAPK pathways. In addition, we found tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell death. Currently, I have mentored 4 post doctors, 4 PhD candidates, and 30 MSc candidates; we published more than 150 papers.

英文名

Li Duan

聯系郵箱

[email protected]

中文簡介

博士，研究員、副主任醫師、博士生導師、深圳市第二人民醫院中心實驗室副主任。先后在荷蘭格羅寧根大學、中山大學從事博士后研究工作，日本福岡齒科大學從事訪問學者研究工作。主持國家科技部外國青年人才計劃、國家自然科學基金、廣東省自然科學基金重點項目和廣東省國際合作項目等20項。發表SCI論文51篇，授權發明專利12項。從事納米載藥治療骨骼肌肉系統疾病。參與的研究成果先后獲得中華醫學科技獎三等獎、廣東省科技進步三等獎和深圳市科技進步二等獎。

英文簡介

Dr Duan is a full-time researcher and vice director of Central Lab at Shenzhen Second People’s Hospital, the First Affiliated Hospital of Shenzhen University. After receiving her PhD from Wuhan University, she was a postdoctoral fellow in the Medical Center of Groningen University and Sun Yat-Sen University, then a visiting scholar in the department of Molecular Biology at the Fukuoka Dental College.

Her main research interests are the nanoparticle delivery for musculoskeletal system disease treatment. Dr Duan has received many awards such as Third prize of Chinese medical science (2017). She received many research grants, including National Natural Science Foundation of China and European Orthodontic Society. Her total research funding was more than RMB￥12,000,000. She has published 50 peer-reviewed articles, several books and book chapters.

英文名

Li Jianjun

聯系郵箱

[email protected]

中文簡介

從事骨科、運動醫學、脊柱脊髓損傷的臨床康復與研究。享受國務院政府特殊津貼。兼任國務院殘工委專家委員會副主委、國際脊髓學會外事委員會和中國分會主席、國際物理醫學與康復學會AIM理事、德國外科學會和日本康復醫學會榮譽會員、中國醫師協會康復醫師分會第四屆會長。榮獲國際著名的 “Rick Hansen Outstanding Award”和“HAIM RING AWARD”。以第一完成人獲中國康復醫學會科學技術獎一等獎2項、北京市科學技術獎三等獎1項、北京醫學科技獎二等獎1項、“全國百名優秀院長”、“四川抗震救災一線突出貢獻獎”，主持或參與國家級、省部級以及局級課題60余項，以一作、通訊作者發表SCI論文77篇，中文論文262篇；主編、參編專著50部。

英文簡介

Li Jianjun, professor, recipient of a special allowance from the State Council, specializes in clinical rehabilitation and research in orthopedics, sports medicine, and spinal cord injuries. He has successfully applied for 60 projects ,published 77 SCI papers and 262 Chinese papers, and has served as the editor for 50 publications.

Deputy Chairman of the Expert Committee of the State Council's Disabled Persons Committee

Vice President of the International Spinal Cord Society

Chairman of the China Branch of the International Society for Physical and Rehabilitation Medicine

Honorary Member of the German Society and the Japanese Association of Rehabilitation Physicians

Awards:

Top 100 Outstanding Deans in the Country

Rick Hansen Outstanding Award, "Haim Ring Award."

the first prize of the China Rehabilitation Medicine Association's Science and Technology Award

the third prize of the Beijing Science and Technology Award

the second prize of the Beijing Medical Science and Technology Award

Sichuan First-Line Contribution Award for Earthquake Relief

英文名

Cheng Gao

聯系郵箱

[email protected]

中文簡介

深圳大學“百人計劃”助理教授，博士生導師。研究工作聚焦于細胞原基材料的結構組裝和生物效應研究，主要包括（1）細胞原基材料的胞外、細胞膜和胞內組裝；（2）細胞原基材料中和效應和中和治療；（3）細胞原基材料靶向識別和藥物遞送。以第一和通訊作者身份在Sci. Adv.（2篇）、Matter、Nat. Commun.（3篇）、Adv. Mater.、J. Am. Chem. Soc.、Mater. Today（2篇）、ACS Nano、Adv. Funct. Mater.、Nano Lett.（2篇）、J. Control. Release等發表論文20余篇，相關研究工作被Nat. Rev. Cardiol.和Matter等選為研究亮點進行專題評論。

英文簡介

Dr. Gao is researcher in School of Pharmacy at Shenzhen University Medical School. He received her PhD degree in 2020, and continued post-doctoral training at University of Macau. He is an expert in the field of cell-primitive biomimetic material. His research focuses on exploring and developing new strategies and technologies that apply biomimetic and natural vehicles for directly disease treatment and synergistically delivering therapeutics in controlled fashion. By accumulating and integrating tools of pharmacology, biomedical engineering and materials science, he designed membrane camouflaged vehicle, cell-based system and intracellularly gelated cell, which are inspired by natural particulates, from bacterial to cells. Dr. Gao has published extensively in leading journals as first author or corresponding author, including two Sci. Adv., three Nat. Commun., one Matter, one Adv. Mater., one J. Am. Chem. Soc., two Mater. Today, one Adv. Func. Mater., one ACS Nano, one J. Control. Release and two Nano Lett.

英文名

Dixian Luo

聯系郵箱

[email protected]

中文簡介

醫學博士、二級研究員、主任技師、國務院政府特殊津貼專家、深圳大學和湖南中醫藥大學教授、留美歸國學者，南方醫科大學和深圳大學臨床檢驗診斷學博士生導師、深圳市衛生健康菁英人才學科帶頭人、深圳市高層次人才（地方領軍級）、CNAS ISO15189評審員、國家自然科學基金函審專家、湖南121中青年領軍人才、高通量分子診斷技術國家地方聯合工程實驗室執行主任。目前擔任擔任中國抗癌協會腫瘤標志專委會鼻咽癌標志專家委員會副主委，廣東省轉化醫學學會分子診斷學分會主委委員、深圳市醫學會醫學微生態專委會副主委，深圳市醫師協會精準醫學分會副會長、深圳市醫院協會檢驗醫學分會副會長等學術任職。主要從事臨床檢驗診斷學臨床和科教工作，研究方向為腫瘤標志物與腫瘤代謝免疫、腫瘤微生物分子診斷技術研發。參與編寫專著或共識5部；主持國家自然科學基金面上項目、國家重點研發計劃子課題、省杰出青年基金、省重點研發計劃、省戰略新興產業專項、市重點研發計劃等30余項；發表論文80余篇，其中SCI論文63篇，IF>10分10篇；申請專利32項，其中授權專利15項；出版專著6部（其中主編2部主編4部）；獲得湖南省科技進步2項和湖南省醫學科技1項。

英文簡介

M.D., Ph.D., Professor at Shenzhen University, Doctoral Supervisor in Clinical Laboratory Diagnostics at Shenzhen University. Discipline Leader of Shenzhen Health Elite Talent Program.Shenzhen High-Level Talent (Local Leading Category).CNAS ISO15189 Accredited Assessor. Peer-review Expert for the National Natural Science Foundation of China （NSFC). Recipient of the Hunan 121 Leading Talent Program for Young and Middle-aged Professionals.Executive Director of the National-Local Joint Engineering Laboratory for High-throughput Molecular Diagnostics.Research Focus:Engaged in clinical and scientific research in clinical laboratory diagnostics, with a focus on tumor biomarkers, tumor metabolic immunology, and the development of molecular diagnostic technologies for tumor-related microbes. Achievements:Contributed to 5 academic monographs/expert consensus guidelines, Led over 30 research projects (including NSFC General Program, Sub-project of the National Key R&D Program, Provincial Outstanding Youth Foundation), Published 80+ papers, including 63 SCI-indexed articles (10 with Impact Factor >10), Filed 32 patents (15 authorized), Awarded two Hunan Provincial Science and Technology Progress Awards and one Hunan Medical Science and Technology Award.